Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. infection results
Show results for
Products
Services
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Infection Results Articles & Analysis

29 news found

Advanced Lung Function Measurement In A Novel HIV/Tuberculosis Co-Infection Mouse Model

Advanced Lung Function Measurement In A Novel HIV/Tuberculosis Co-Infection Mouse Model

Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) are major global health threats. Their interaction worsens disease severity, as HIV reduces CD4+ T cells, making individuals more vulnerable to TB. Despite progress, an effective animal model that mimics human immune response during HIV/TB co-infection has been lacking, hindering treatment and vaccine development. Bohorguez et al. ...

BySCIREQ - an emka TECHNOLOGIES Company


Creative Diagnostics Announces High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay Development

Creative Diagnostics Announces High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay Development

Culture is the gold standard for diagnosis of adenovirus infection. However, culture results can take up to 3 weeks. Serological tests have a faster turnaround time but may not be as sensitive as culture. Because of the clinical importance of rapid laboratory diagnosis, direct detection of viral antigens in nasopharyngeal secretions, feces, or both is used as the ...

ByCreative Diagnostics


China risks between 1.3 and 2.1 million deaths if it ends its zero-COVID strategy

China risks between 1.3 and 2.1 million deaths if it ends its zero-COVID strategy

Analysis by Airfinity shows between 1.3 and 2.1 million lives could be at risk if China lifts its zero-COVID policy given low vaccination and booster rates as well as a lack of hybrid immunity. Airfinity’s risk analysis uses cumulative peak cases and deaths from Hong Kong's BA.1 wave as a proxy for mainland China. Hong Kong took a zero-COVID approach for the first two years of the ...

ByAirfinity Limited


Ondine’s photodisinfection kills ESKAPE pathogens

Ondine’s photodisinfection kills ESKAPE pathogens

[i] ESKAPE pathogens are the most virulent and dangerous pathogens responsible for some of the deadliest healthcare-associated infections (HAIs). Results of the study showed that Ondine’s photodisinfection technology eliminated all ESKAPE pathogens with a high degree of efficacy. This parallels the top-line results from a US Phase 2 study ...

ByOndine Biomedical Inc


Bit225 Effective Against Established Sars-Cov-2 in Animals

Bit225 Effective Against Established Sars-Cov-2 in Animals

In a significant step forward, new data shows that BIT225 protects from severe disease even when started once there is an established infection. Mice commencing treatment with BIT225 after infection with SARS-CoV-2 had similar levels of protection against severe disease as mice commencing treatment with BIT225 prior to infection. ...

ByBiotron Limited


Cytovale IntelliSep Test Demonstrates Potential to Rapidly Risk-Stratify Suspected COVID-19 Patients in New Study

Cytovale IntelliSep Test Demonstrates Potential to Rapidly Risk-Stratify Suspected COVID-19 Patients in New Study

Data from the study shows that Cytovale’s test has the potential to provide useful prognostic information for patients with suspected infection and possible immune dysregulation that can lead to life-threatening organ dysfunction. To see video, please click here This study, which enrolled 282 patients presenting to the Emergency Department (ED) with respiratory symptoms ...

ByCytovale Inc.


Atriva Therapeutics receives U.S. FDA Orphan Drug Designation for Zapnometinib to treat Hantavirus Infections

Atriva Therapeutics receives U.S. FDA Orphan Drug Designation for Zapnometinib to treat Hantavirus Infections

FDA Orphan Drug Designation (ODD) underscores strength of Atriva’s pipeline and high need for treatments for rare and neglected tropical diseases ODD allows Atriva to benefit from various incentives to develop zapnometinib (ATR-002) against hantavirus infections, and may result in seven-year market exclusivity on approval for this indication Targeting ...

ByAtriva Therapeutics GmbH


Creative Proteomics Launches Oncology Multi-omics Platform to Promote Basic Oncology Research

Creative Proteomics Launches Oncology Multi-omics Platform to Promote Basic Oncology Research

In the total proteome, three biological pathways related to bacterial infection were found. The results showed that bacteria may be a key factor in the occurrence of biliary tract cancer. ...

ByCreative Proteomics


Microlyte SURGICAL Associated with Positive Outcomes in Prospective Clinical Case Series in Patients at Risk for Surgical Site Infection

Microlyte SURGICAL Associated with Positive Outcomes in Prospective Clinical Case Series in Patients at Risk for Surgical Site Infection

(Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a prospective clinical evaluation of its next-generation wound Matrix, Microlyte® SURGICAL, in diabetic patients undergoing foot and ankle surgery who would ordinarily be at risk of a surgical site infection. Results will be ...

ByImbed Biosciences


Bonesupport – Supplementary Us Denovo Application Submitted

Bonesupport – Supplementary Us Denovo Application Submitted

The application is specified for the indication osteomyelitis (bone infection) and can potentially result in an approval in Q1 of 2022. In February of this year, the FDA requested further data and clarifications on BONESUPPORT’s DeNovo application. ...

ByBONESUPPORT AB


NIAID awards Phase I contract to Kephera Diagnostics for the development of a new test for Chagas disease

NIAID awards Phase I contract to Kephera Diagnostics for the development of a new test for Chagas disease

It is the most prevalent parasitic disease in the western hemisphere, infecting 6-7 million people with over 70 million at risk. Moreover, CDC estimates approximately 300,000 cases in the U.S., principally among individuals who acquired it in endemic countries, although some autochthonous infections have also been reported. Chagas can also be transmitted ...

ByKephera Diagnostics, LLC


Ferring to Present Award-Winning, Landmark Research for Investigational Microbiota-Based Live Biotherapeutic RBX2660 at IDWeek 2021

Ferring to Present Award-Winning, Landmark Research for Investigational Microbiota-Based Live Biotherapeutic RBX2660 at IDWeek 2021

Riddle DJ, Dubberke ER. Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am. 2009;23(3):727-743. ...

ByRebiotix Inc., a Ferring Company


UVD Robots Deploys Robot #200 donated by The European Commission to European hospitals

UVD Robots Deploys Robot #200 donated by The European Commission to European hospitals

Each year millions of patients are infected and thousands of patients die due to infections acquired during hospitalisation. ...

ByUVD Robots, PART OF BLUE OCEAN ROBOTICS


UVD Robots Deploys Robot #200 donated by The European Commission to European hospitals

UVD Robots Deploys Robot #200 donated by The European Commission to European hospitals

Each year millions of patients are infected and thousands of patients die due to infections acquired during hospitalisation. ...

ByBlue Ocean Robotics


TriMedika Growth Ahead of US Market Entry

TriMedika Growth Ahead of US Market Entry

There is now a greater awareness of the benefits of non-contact in regard to infection control, as a result of the Covid-19 pandemic. The company now distributes TRITEMP in over 21 countries across the globe, listed on major procurement frameworks including NHS Supply Chain. ...

ByTriMedika


Evaxion Biotech Announces Publication of Study on S. aureus Bacterium in Scientific Reports

Evaxion Biotech Announces Publication of Study on S. aureus Bacterium in Scientific Reports

Andersen, to characterize how pathogen and host respond to infection with S. aureus in human endothelial cells. S. aureus is a leading cause of serious bloodstream infections worldwide, such as infectious endocarditis and sepsis, which have been recognized as difficult to treat and often require intensive and prolonged antibiotic treatment. ...

ByEvaxion Biotech A/S


Miamitech Startup Spotlight: Dalent Aims to Improve Sinus Surgery Experience, Outcome and Cost

Miamitech Startup Spotlight: Dalent Aims to Improve Sinus Surgery Experience, Outcome and Cost

If you’ve ever had an awful sinus infection, you know how painful, and quite frankly, how much of a drag it is. But most of us don’t have Chronic Sinusitis, which consists of a sinus infection lasting longer than 3 months (despite treatment), according to the Mayo Clinic. ...

ByDalent Medical


Louisiana’s First Prosthetic Iris Implant Performed at AVALA

Louisiana’s First Prosthetic Iris Implant Performed at AVALA

The CUSTOMFLEX® ARTIFICIALIRIS Veo Ophthalmics implant was used to treat disabling glare as a result of infection over 15 years ago. This surgery has never been performed in Louisiana and we are proud to offer some of the most innovative healthcare solutions to our community and beyond! ...

ByVEO Ophthalmics, LLC


OtoNexus Medical Technologies Wins 2020 Red Herring Top 100 North America Award

OtoNexus Medical Technologies Wins 2020 Red Herring Top 100 North America Award

OtoNexus has developed the world's first ultrasound hand-held device to evaluate middle ear infections. With the tools available today, detection accuracy is approximately 50% in the critical differentiation of viral versus bacterial infections. As a result, middle ear infections are the #1 reason for antibiotic prescriptions ...

ByOtoNexus Medical Technologies Inc.


OtoNexus Medical Technologies Wins Prestigious Most Valued Company Award at Keiretsu Forum Investor Capital Expo

OtoNexus Medical Technologies Wins Prestigious Most Valued Company Award at Keiretsu Forum Investor Capital Expo

OtoNexus has developed the world's first ultrasound hand-held device to evaluate the four disease states of middle ear infection. With the tools available today, detection accuracy is approximately 50% in the critical differentiation of viral versus bacterial infections. As a result, middle ear infections are the #1 reason for ...

ByOtoNexus Medical Technologies Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT